Journal of AIDS and HIV Treatment

Commentary Open Access

Pre-exposure Prophylaxis (PrEP) for HIV Infection and New Sexually Transmitted Infections: A Win-Win Opportunity?

François Aubin, Clélia Vanhaecke, Christine Drobacheff, Fabien Pelletier, Manuelle Viguier

Pre-exposure prophylaxis (PrEP) significantly reduces the risk of HIV acquisition in patients exposed to a high risk of infection such as men who have sex with men (MSM), heterosexual couples, and people who inject drugs.

Commentary Open Access

Dihydropteroate Synthase (DHPS) Gene Mutations in Human Pneumocystosis

Bijay Ranjan Mirdha

Extraordinary journey began on June 18, 1981, the Centre for Disease Control and Prevention (CDC) in United States reported a cluster of Pneumocystis carinii pneumonia (now known as Pneumocystis jirovecii (P. jirovecii) pneumonia or Pneumocystis pneumonia in five gay men in Los Angeles.

Research Article Open Access

Assessment of Attitudes toward HIV and AIDS among Undergraduate Students at a Historically Black University

Prince Andrew, Azad R. Bhuiyan, Anthony Mawson, Mohammad Shahbazi

HIV is no longer only a public health challenge, but also a global threat with a devastating negative impact that has claimed over 35 million lives globally. In 2017, about 36.9 million people live with HIV, and 1.8 million people becoming newly infected with the disease globally [1].

Research Article Open Access

HIV-1 Treatment Failure among Population Taking Antiretroviral Therapy in Ethiopia

Atsbeha G Egziabhier, Kidist Zealiyas, Rahel Tilahun, Mulu Girma, Gebremedihin G/Michael, Tekalign Deressa, Ebba Abate, Desta Kassa, Yibeltal Assefa

For more than 35 years, the world has grappled with an AIDS epidemic that has claimed an estimated 35.0 million [28.9 million-41.5 million] lives and at its peak threatened global stability and security.

Research Article Open Access

Development of an Ultrasensitive HIV-1 DNA Detection Assay Based on an Automated πCode End-Point PCR System

Kazuo Suzuki, Jui-Yu Hu, Takaomi Ishida, Yuhung Lin, Satoshi Minote, Zhixin Liu, Julie Yeung, Leon Patrick McNally, Mitchell Starr, Angelique Levert, Philip Cunningham, John Zaunders, Chin-Shiou Huang

Currently, around 60-75% of the HIV positive patients in developed countries on anti-retroviral therapy (ART) have undetectable plasma viral load using current diagnostic PCR assays.